The market's recovery could continue into 2024 -- and these stocks should benefit. Medtronic boasts a steady business and an incredible dividend track record.

Medtronic: On The Verge Of A Massive Turnaround

04:30pm, Thursday, 30'th Nov 2023
Medtronic's recent earnings report has boosted investor confidence, suggesting the worst may be over for the company. The impact of the weight loss drugs on Medtronic's long-term growth prospects is e

Medtronic Stock: Bull vs. Bear

06:00am, Wednesday, 29'th Nov 2023
Medtronic has revamped its business to favor growth. There are other stocks out there offering higher growth rates and longer streaks of payout hikes.
The top tech stocks are always a point of contention among investors. Some prefer sticking with reliable companies like the Magnificent 7, while others decry the same for being grossly overvalued.
Medtronic is a well-diversified healthcare company with strong secular growth and pricing power. The company has four major business segments, each contributing over $2 billion in annual revenue. Medt

10 Dividend Growth Stocks For November 2023

08:06am, Tuesday, 28'th Nov 2023
In my monthly series of 10 Dividend Growth Stocks, I rank a selection of Dividend Radar stocks and present the 10 top-ranked stocks for further research and possible investment. This month, I'm presen
The stock market is enjoying some holiday cheer. Amid signs that inflation is letting up and the Federal Reserve may finally put an end to its rate hikes, traders are piling into all sorts of investme

Is Medtronic a Good Dividend Stock to Buy Now?

05:21am, Saturday, 25'th Nov 2023
Medtronic has a history of raising its dividend rapidly, but its pace has slowed down. Fiscal second-quarter sales earnings fell slightly, and the company's predictions for the next six months aren't
Medtronic (NYSE: MDT) recently reported its Q2 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating our estimates, and we believe that MDT st
Chevron's growing dividend has enabled it to produce enriching returns. Coca-Cola's ability to grow hasn't fizzled out.
Medtronic has been working to get key products across the finish line. The company is jettisoning slower-growing divisions so it can focus on growth.
After two years of correction and downtrend, providing ample incentive to buyers all along the way, medical device maker Medtronic NYSE: MDT has finally reached its bottom, and the reversal is on. The
The medical-devices specialist published its latest set of quarterly results. Happily for its shareholders, the company managed to grow on both the top and bottom lines and beat analyst estimates.
Geoff Martha, Medtronic CEO, joins 'Closing Bell Overtime' to talk quarterly results, the impact of weight-loss drugs, and more.
Medtronic (MDT) Q2 results reflect broad strength across businesses and geographies, benefiting from durable fundamentals.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE